K2 and Beyond: A Synthetic Cannabinoid Primer
The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry
The Challenges of Analytical Method Validation for Hallucinogens and Designer Stimulants in Biological Samples Using LC-TOF
Developments in Toxicology Support for the DRE Community
Pharmacodynamics and Pharmacokinetics of Synthetic Cannabinoids
Increasing Diversity of Chemicals in Synthetic Stimulant and Cathinone Cases
Oral Fluid as a Chemical Test for the DRE Program
K2 and the Synthetic Cannabinoids: Pharmacology, Effects and Chemical Analysis
Trends Report on Changes in the Designer Drug Market: Spring 2012
New Highs: Salvia and K 2 - Solutions for the DRE
NMS Labs introduction
Designer Drugs Testing Solutions for Employers
Salvia: Effects, Legal Status and Analysis
Testing for BPA and other EDCs
NMS Labs Dinner Presentation by Dr. Andrea Gore 5-27-10
Julie Ruth Resume January 2017